BEAT News and Press, Heartbeam Inc. From 10/29/20

MALVERN, Pa., Oct. 29, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended September 30, 2...

BioTelemetry (NASDAQ:BEAT) is scheduled to announce Q3 earnings results on Thursday, October 29th, after market close.The consensus EPS Estimate is $0.38 (-26.9% Y/Y) and the consensus Revenue Estimate is $105.12M (-5.6% Y/Y).Over the last 2 years, BEAT has beaten EPS estimates 100% of the ti...

MALVERN, Pa., Oct. 22, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2020 earnings on Thursday, October 29 at 4:00 PM Eastern Time. BioTelemetry, Inc. will host an earnings conference call on Thursday, October 29, at 5:00 PM Eastern Time. ...

G Medical Innovations is seeking $30 million in a U.S. IPO. The firm sells cardiac monitoring products and services. GMVD has suffered contracting revenue, has an uncertain future in a continuing Covid-19 environment and the IPO is excessively priced, so I'll pass. For furth...

BioTelemetry (BEAT) came public as CardioNet in 2008; the company provides remote cardiac monitoring for medical diagnostics and clinical trials and is pushing into other outpatient monitoring markets, asserts growth stock expert Doug Gerlach, editor of Investor Advisory Service. For furthe...

Needham initiated BioTelemtry ( BEAT +6.0% ) with a Buy rating, price target of $52, indicating upside of 33% from current levels. More news on: BioTelemetry, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Image source: The Motley Fool. BioTelemetry Inc   (NASDAQ: BEAT) Q2 2020 Earnings Call Jul 30, 2020 , 5:00 p.m. ET Operator Continue reading

BioTelemetry, Inc. (BEAT) Q2 2020 Earnings Conference Call July 30, 2020 5:00 PM ET Company Participants Joseph Capper – President and Chief Executive Officer Heather Getz – Chief Financial Officer Conference Call Participants Kaila Krum – SunTrust Broo...

BioTelemetry (NASDAQ: BEAT ) : Q2 Non-GAAP EPS of $0.35; GAAP EPS of $0.06 beats by $0.08 . More news on: BioTelemetry, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...

MALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended June 30, 2020. ...